gemcitabine 200 mg/5mL (Gemcitabine Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 200 mg/5mL

Gemcitabine 200 mg/5mL is a lyophilized powder for solution, used for intravenous administration. This antimetabolite is commonly prescribed for certain types of cancer. Learn more about its uses and effects.

Strength

200 mg/5mL

Pack Size

1 VIAL in 1 CARTON (25021-234-10) / 5 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells. Patients often wonder, 'What is gemcitabine used for?' This medication is typically administered intravenously and is part of a broader cancer treatment plan.

Side Effects

Common effects of gemcitabine may include fatigue, nausea, and a decreased appetite. Some patients may also experience hair loss or changes in their blood cell counts. These effects can vary widely depending on the individual and the specific treatment plan.

Precautions & Warnings

Gemcitabine should be handled with care, as it is a potent medication. It is important to follow the instructions provided by your healthcare provider. Always store gemcitabine in a safe place, away from children and pets. Proper disposal methods should be followed to ensure safety.

Avoid Interactions

Gemcitabine may interact with other medications, including certain chemotherapy drugs and immunosuppressants. It is important to inform your healthcare provider about all medications you are taking. Alcohol and other substances may also interact with gemcitabine, so it is best to avoid them unless advised otherwise.

Frequently Asked Questions

Gemcitabine is primarily used in the treatment of various types of cancer, often as part of a broader treatment plan.

Gemcitabine is administered intravenously after being reconstituted from its lyophilized powder form.

Common side effects may include fatigue, nausea, and changes in blood cell counts.

Gemcitabine may interact with other medications, so it is important to consult your healthcare provider before combining it with other treatments.

Gemcitabine should be stored in a safe place, away from children and pets, following the specific storage instructions provided.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.